Hot Features
Premium
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Period:
Draw Mode:
| Volume | 311,625 |
|
|||||
| News | - | ||||||
| Day High | 15.355 | Low High |
|||||
| Day Low | 14.93 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Immunome Inc | IMNM | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.05 | 0.33% | 15.20 | 15:18:22 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 14.93 | 14.93 | 15.355 | 15.20 | 15.15 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 5,843 | 311,625 | US$ 15.12 | US$ 4,711,414 | - | 4.50 - 30.958 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 15:01:30 | priorref | 696 | US$ 15.20 | USD |
Immunome Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 648.21M | 42.73M | - | 14.02M | -106.81M | -2.50 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Immunome News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical IMNM Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 15.32 | 15.81 | 13.895 | 14.87 | 937,024 | -0.12 | -0.78% |
| 1 Month | 15.69 | 16.79 | 13.515 | 14.62 | 905,384 | -0.49 | -3.12% |
| 3 Months | 22.15 | 26.70 | 13.515 | 16.99 | 780,670 | -6.95 | -31.38% |
| 6 Months | 7.84 | 30.958 | 6.93 | 18.21 | 702,662 | 7.36 | 93.88% |
| 1 Year | 4.94 | 30.958 | 4.50 | 16.26 | 430,513 | 10.26 | 207.69% |
| 3 Years | 20.01 | 30.958 | 2.09 | 15.50 | 219,157 | -4.81 | -24.04% |
| 5 Years | 15.66 | 63.78 | 2.09 | 17.34 | 206,518 | -0.46 | -2.94% |
Immunome Description
| Immunome Inc is a biopharmaceutical company. It is engaged in utilizing proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The company's primary focus areas are oncology and infectious disease, including COVID-19. |
